118 related articles for article (PubMed ID: 31228326)
21. HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.
Sun H; Liu T; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y
Genes Chromosomes Cancer; 2017 Aug; 56(8):598-607. PubMed ID: 28393427
[TBL] [Abstract][Full Text] [Related]
22. MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.
Lu YC; Cheng AJ; Lee LY; You GR; Li YL; Chen HY; Chang JT
Sci Rep; 2017 May; 7(1):2042. PubMed ID: 28515423
[TBL] [Abstract][Full Text] [Related]
23. POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Int J Cancer; 2017 Jun; 140(11):2517-2525. PubMed ID: 28214331
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of novel inhibitors of Mammalian aspartyl aminopeptidase.
Chen Y; Tang H; Seibel W; Papoian R; Oh K; Li X; Zhang J; Golczak M; Palczewski K; Kiser PD
Mol Pharmacol; 2014 Aug; 86(2):231-42. PubMed ID: 24913940
[TBL] [Abstract][Full Text] [Related]
25. KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion.
Al-Mansoob M; Gupta I; Stefan Rusyniak R; Ouhtit A
J Cell Mol Med; 2021 Mar; 25(5):2309-2314. PubMed ID: 33486887
[TBL] [Abstract][Full Text] [Related]
26. High GD2 expression defines breast cancer cells with enhanced invasiveness.
Mansoori M; Roudi R; Abbasi A; Abolhasani M; Abdi Rad I; Shariftabrizi A; Madjd Z
Exp Mol Pathol; 2019 Aug; 109():25-35. PubMed ID: 31075227
[TBL] [Abstract][Full Text] [Related]
27. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
[TBL] [Abstract][Full Text] [Related]
28. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of S100A10 in metastasized breast cancer stem cells.
Yanagi H; Watanabe T; Nishimura T; Hayashi T; Kono S; Tsuchida H; Hirata M; Kijima Y; Takao S; Okada S; Suzuki M; Imaizumi K; Kawada K; Minami H; Gotoh N; Shimono Y
Cancer Sci; 2020 Dec; 111(12):4359-4370. PubMed ID: 32976661
[TBL] [Abstract][Full Text] [Related]
30. Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.
Ijuin T; Takeuchi Y; Shimono Y; Fukumoto M; Tokuda E; Takenawa T
Cancer Sci; 2016 Jul; 107(7):981-90. PubMed ID: 27178239
[TBL] [Abstract][Full Text] [Related]
31. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
Zheng M; Sun X; Li Y; Zuo W
Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
[TBL] [Abstract][Full Text] [Related]
33. DNPEP is not the only peptidase that produces SPAK fragments in kidney.
Koumangoye R; Delpire E
Physiol Rep; 2017 Nov; 5(21):. PubMed ID: 29122955
[TBL] [Abstract][Full Text] [Related]
34. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
35. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan-CD44 axis orchestrates cancer stem cell functions.
Skandalis SS; Karalis TT; Chatzopoulos A; Karamanos NK
Cell Signal; 2019 Nov; 63():109377. PubMed ID: 31362044
[TBL] [Abstract][Full Text] [Related]
37. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
Nami B; Donmez H; Kocak N
Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
[TBL] [Abstract][Full Text] [Related]
38. Amino-terminal fragments of laminin γ2 chain stimulate migration of metastatic breast cancer cells by interacting with CD44.
Sato H; Higashi S; Miyazaki K
Clin Exp Metastasis; 2015 Jun; 32(5):405-15. PubMed ID: 25990436
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway.
Sarkar A; Chanda A; Regmi SC; Karve K; Deng L; Jay GD; Jirik FR; Schmidt TA; Bonni S
PLoS One; 2019; 14(7):e0219697. PubMed ID: 31361756
[TBL] [Abstract][Full Text] [Related]
40. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]